Johanna Mercier Gilead Sciences, Inc. (GILD) insider trading activity

Johanna Mercier is Chief Commercial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 117,168 shares of GILD, which is worth approximately $12.7 Million. The most recent transaction as insider was on Dec 10, 2023, when has been sold 1,247 shares (Common Stock) at a price of $79.02 per share, resulting in proceeds of $98,537. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K

5.63% 3M change

2.74% 12M change

Total Value Held $12.7 Million

Johanna Mercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2023	SELL Payment of exercise price or tax liability	$98,537 $79.02 p/Share	1,247 Reduced 1.35%	90,971 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 2.88%	92,218 Common Stock
Sep 10 2023	SELL Payment of exercise price or tax liability	$95,456 $76.0 p/Share	1,256 Reduced 1.38%	89,488 Common Stock
Sep 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 2.92%	90,744 Common Stock
Jul 24 2023	SELL Payment of exercise price or tax liability	$246,492 $77.66 p/Share	3,174 Reduced 6.16%	48,326 Common Stock
Jul 24 2023	BUY Exercise of conversion of derivative security	-	7,505 Added 12.72%	51,500 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$99,368 $78.12 p/Share	1,272 Reduced 2.81%	43,995 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 5.69%	45,267 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$406,722 $79.5 p/Share	5,116 Reduced 5.86%	82,225 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	10,976 Added 11.16%	87,341 Common Stock
Jan 24 2023	SELL Payment of exercise price or tax liability	$1,287,606 $84.02 p/Share	15,325 Reduced 16.71%	76,365 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	67,394 Added 42.36%	91,690 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$40,730 $87.97 p/Share	463 Reduced 1.13%	40,430 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.36%	40,893 Common Stock
Sep 10 2022	SELL Payment of exercise price or tax liability	$29,898 $65.28 p/Share	458 Reduced 1.13%	39,903 Common Stock
Sep 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.39%	40,361 Common Stock
Jul 24 2022	SELL Payment of exercise price or tax liability	$194,925 $60.8 p/Share	3,206 Reduced 7.53%	39,371 Common Stock
Jul 24 2022	BUY Exercise of conversion of derivative security	-	7,505 Added 14.99%	42,577 Common Stock
Jun 10 2022	SELL Payment of exercise price or tax liability	$28,062 $60.74 p/Share	462 Reduced 1.3%	35,072 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.71%	35,534 Common Stock
Mar 10 2022	SELL Payment of exercise price or tax liability	$186,560 $57.92 p/Share	3,221 Reduced 8.53%	34,544 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	-	6,987 Added 15.61%	37,765 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	18,630 Added 37.71%	30,778 Common Stock
Jul 24 2021	SELL Payment of exercise price or tax liability	$236,393 $69.02 p/Share	3,425 Reduced 21.99%	12,148 Common Stock
Jul 24 2021	BUY Exercise of conversion of derivative security	-	7,505 Added 32.52%	15,573 Common Stock

Also insider at

NBIX

NEUROCRINE BIOSCIENCES INC Healthcare

Director

Johanna Mercier

Chief Commercial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account